A Study of the Activity of Eculizumab for Prevention of Delayed Graft Function In Deceased Donor Kidney Transplant
Status:
Terminated
Trial end date:
2014-02-06
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if Eculizumab is safe and effective in the
prevention of delayed graft function following deceased donor kidney transplantation.